Skip to content
Contact
☰
About
Mission & Vision
Management Team
Board of Directors
Collaborations & Partnerships
Science
Epigenetic Scientific Platform
Preclinical Discovery Programs
Publications & Presentations
Clinical Development
Clinical Programs
Clinical Trials
Expanded Access Policy
Investigator Sponsored Trials
Medical Education & Sponsorship
Medicines
Investors & Media
Overview
Press Releases
Events & Presentations
Financial Information
SEC Filings
Quarterly Results
Annual Report & Proxy
Stock Information
Stock Quote
Stock Chart
Analyst Coverage
Corporate Governance
Management Team
Board of Directors
Committee Composition
Corporate Governance Documents
Resources
Investor FAQs
Contact Us
Careers
Medicines
Medicines
Learn more about TAZVERIK
®
(tazemetostat) by downloading the full Prescribing Information below or by visiting the U.S. product website.
Full U.S. Prescribing Information
TAZVERIK.com
(for U.S. HCPs)
